What We Study

Population Bio’s Drug Development Research Programs

  • Drug safety, identify genetic variants that increase the risk of a serious adverse event (SAE) to pre-screen patients before taking the drug.
  • Drug repurposing, identify genetic subtypes of common diseases that can match patients to approved drugs as a new indication.
  • Drug rescue, identify genetic variants for responders in clinical trials (patient stratification) of novel therapies and enable drug approval.

Population Bio’s Disease Research Pipeline

  • Endometriosis
  • Autism Spectrum Disorder
  • Parkinson’s Disease
  • Alzheimer’s Disease (Late-Onset)
  • Food Allergy (Peanut)
  • Unsolved Pediatric Syndromes